Mount Yale Investment Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Mount Yale Investment Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $30,446 - $55,534	-488 Reduced 5.02%	9,236 $1.05 Million
Q3 2022 Nov 07, 2022	SELL	$58.92 - $84.67 $29,106 - $41,826	-494 Reduced 4.83%	9,724 $602,000
Q2 2022 Aug 02, 2022	SELL	$79.4 - $116.36 $49,942 - $73,190	-629 Reduced 5.8%	10,218 $815,000
Q1 2022 May 03, 2022	SELL	$86.42 - $109.81 $95,753 - $121,669	-1,108 Reduced 9.27%	10,847 $1.14 Million
Q4 2021 Feb 02, 2022	SELL	$98.56 - $119.91 $17,149 - $20,864	-174 Reduced 1.43%	11,955 $1.29 Million

Q3 2021 Nov 02, 2021	SELL	$91.91 - $110.37 $13,418 - $16,114	-146 Reduced 1.19%	12,129 $1.33 Million
Q2 2021 Aug 04, 2021	SELL	$86.24 - $95.92 $142,640 - $158,651	-1,654 Reduced 11.87%	12,275 $1.15 Million
Q1 2021 May 04, 2021	SELL	$71.83 - $95.48 $42,451 - $56,428	-591 Reduced 4.07%	13,929 $1.28 Million
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $82,142 - $103,462	-1,226 Reduced 7.79%	14,520 $1.06 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $104,274 - $150,907	-1,888 Reduced 10.71%	15,746 $1.22 Million
Q2 2020 Jul 09, 2020	BUY	$30.2 - $56.98 $300,218 - $566,438	9,941 Added 129.22%	17,634 $980,000
Q1 2020 May 04, 2020	BUY	$24.87 - $38.56 $31,659 - $49,086	1,273 Added 19.83%	7,693 $228,000
Q4 2019 Feb 13, 2020	SELL	$25.43 - $36.67 $17,292 - $24,935	-680 Reduced 9.58%	6,420 $221,000
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $16,767 - $20,390	-729 Reduced 9.31%	7,100 $215,000
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $178,579 - $222,969	7,829 New	7,829 $207,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.